Crossmark

A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024

Crossref DOI link: https://doi.org/10.1038/s41598-025-02359-3

Published Online: 2025-05-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Fengjie https://orcid.org/0009-0005-4037-1193
He, Yue https://orcid.org/0009-0003-6027-9357
Ou, Wenting https://orcid.org/0009-0007-4469-6184
Yang, Na https://orcid.org/0009-0001-3985-4324
Bai, Xueling https://orcid.org/0009-0008-0172-8702
License Information

Text and Data Mining valid from 2025-05-19

Version of Record valid from 2025-05-19
More Information

Article History

Received: 20 November 2024

Accepted: 13 May 2025

First Online: 19 May 2025

Declarations

:

: The authors declare no competing interests.